Pediatrix Medical Group, Inc. Interest Expense Nonoperating
Pediatrix Medical Group, Inc. (MD) reported Interest Expense Nonoperating of $8.17 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Expense Statement › Interest Expense
us-gaap:InterestExpenseNonoperating · last filed 2026-08-04
- Pediatrix Medical Group, Inc. interest expense nonoperating for the quarter ending 2026-06-30 was $8.17M, a 10.49% decline year-over-year.
- Pediatrix Medical Group, Inc. interest expense nonoperating for the quarter ending 2026-03-31 was $8.27M, a 9.71% decline year-over-year.
- Pediatrix Medical Group, Inc. interest expense nonoperating for the quarter ending 2025-12-31 was $8.74M, a 9.99% decline year-over-year.
- Pediatrix Medical Group, Inc. interest expense nonoperating for the quarter ending 2025-09-30 was $8.94M, a 11.70% decline year-over-year.
- Pediatrix Medical Group, Inc. interest expense nonoperating for fiscal 2025 was $35.97M, a 11.73% decline from fiscal 2024.
- Pediatrix Medical Group, Inc. interest expense nonoperating for fiscal 2024 was $40.74M, a 3.17% decline from fiscal 2023.
- Pediatrix Medical Group, Inc. interest expense nonoperating for fiscal 2023 was $42.08M, a 6.00% increase from fiscal 2022.
- Pediatrix Medical Group, Inc. interest expense nonoperating for fiscal 2022 was $39.70M.
| Period end | Interest Expense Nonoperating 3 month | Interest Expense Nonoperating 6 month | Interest Expense Nonoperating 9 month | Interest Expense Nonoperating 12 month |
|---|---|---|---|---|
| 2026-06-30 | $8.17M 10-Q · filed 2026-08-04 | $16.44M 10-Q · filed 2026-08-04 | $25.18M derived: sum of 3 quarters · filed 2026-08-04 | $34.12M derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-03-31 | $8.27M 10-Q · filed 2026-05-05 | $17.00M derived: sum of 2 quarters · filed 2026-05-05 | $25.95M derived: sum of 3 quarters · filed 2026-05-05 | $35.08M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-12-31 | $8.74M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $17.68M derived: sum of 2 quarters · filed 2026-02-19 | $26.81M derived: sum of 3 quarters · filed 2026-08-04 | $35.97M 10-K · filed 2026-02-19 |
| 2025-09-30 | $8.94M 10-Q · filed 2025-11-03 | $18.07M derived: sum of 2 quarters · filed 2026-08-04 | $27.23M 10-Q · filed 2025-11-03 | $36.94M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-06-30 | $9.13M 10-Q · filed 2026-08-04 | $18.28M 10-Q · filed 2026-08-04 | $27.99M derived: sum of 3 quarters · filed 2026-08-04 | $38.12M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-03-31 | $9.15M 10-Q · filed 2026-05-05 | $18.86M derived: sum of 2 quarters · filed 2026-05-05 | $28.99M derived: sum of 3 quarters · filed 2026-05-05 | $39.30M derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | $9.71M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $19.84M derived: sum of 2 quarters · filed 2026-02-19 | $30.14M derived: sum of 3 quarters · filed 2026-02-19 | $40.74M 10-K · filed 2026-02-19 |
| 2024-09-30 | $10.13M 10-Q · filed 2025-11-03 | $20.43M derived: sum of 2 quarters · filed 2025-11-03 | $31.03M 10-Q · filed 2025-11-03 | $41.11M derived: sum of 4 quarters · filed 2026-02-19 |
| 2024-06-30 | $10.31M 10-Q · filed 2025-08-05 | $20.91M 10-Q · filed 2025-08-05 | $30.99M derived: sum of 3 quarters · filed 2026-02-19 | $41.36M derived: sum of 4 quarters · filed 2026-02-19 |
| 2024-03-31 | $10.60M 10-Q · filed 2025-05-06 | $20.68M derived: sum of 2 quarters · filed 2026-02-19 | $31.05M derived: sum of 3 quarters · filed 2026-02-19 | |
| 2023-12-31 | $10.08M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $20.45M derived: sum of 2 quarters · filed 2026-02-19 | $42.08M 10-K · filed 2026-02-19 | |
| 2023-09-30 | $10.37M 10-Q · filed 2024-11-01 | $31.99M 10-Q · filed 2024-11-01 | ||
| 2022-12-31 | $39.70M 10-K · filed 2025-02-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Encompass Health Corp (EHC) | United States | $12.039B | 16.15 |